BioWorld

Feb. 11, 2003

View Archived Issues

Johnson & Johnson Buying Scios For $2.4 Billion In Cash

It's official. Scios Inc. is selling out to Johnson & Johnson in a $2.4 billion cash deal. (BioWorld Today) Read More

OSI Acquiring Cell Pathways In Stock Deal Valued At $32M

Read More

Wistar Immunologists Construct HIV Adenovirus-Based Vaccine Bypassing Prior Vector Immunity

Read More

Biotech Industry Has Nowhere To Go But Up After Dreary Year

Read More

Other News To Note

Read More

Appointments And Advancements

Read More